»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ij¸®¾î ½ºÅ©¸®´× ½ÃÀåÀº 2024-2029³â 38¾ï 9,790¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 22.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ Ä³¸®¾î ½ºÅ©¸®´×(Carrier Screening) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. À¯ÀüÀÚ Áúȯ ¹× Àå¾ÖÀÇ À¯º´·ü Áõ°¡, žÆÀÇ ¿°»öü ÀÌ»ó À¯º´·ü Áõ°¡, Áúº´ÀÇ Á¶±â ¹ß°ß ¹× Áø´ÜÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ´ëÁßÀÇ ÀÎ½Ä Áõ°¡ µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ
2025³â
Á¾·á ¿¬µµ
2029³â
¿¹Ãø ±â°£
2025-2029³â
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ
18.1%
CAGR
22.5%
Áõ°¡¾×
38¾ï 9,790¸¸ ´Þ·¯
ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÇâÈÄ ¸î ³â µ¿¾È ij¸®¾î ½ºÅ©¸®´× ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î Â÷¼¼´ë ¿°±â¼¿ ºÐ¼®(NGS) ±â¼úÀÇ ¹ßÀü Ãß¼¼¸¦ ²Å°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ý¸í°øÇÐ ¹× ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ºÐ¾ßÀÇ ±¤¹üÀ§ÇÑ ¿¬±¸°³¹ß Ȱµ¿°ú ÀÇ·á ÀÎÇÁ¶óÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀº ½ÃÀåÀÇ Å« ¼ö¿ä¸¦ âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå Technavio ºÐ¼®
°¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
ÀÎDzÀÇ Á߿伺°ú Â÷º°È ¿äÀÎ
È¥¶õ ¿äÀÎ
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
Á¦3Àå ½ÃÀå ±¸µµ
½ÃÀå »ýŰè
½ÃÀå Æ¯Â¡
¹ë·ùüÀÎ ºÐ¼®
Á¦4Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð(2024³â)
½ÃÀå Àü¸Á 2024³â-2029³â
Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¼¼°èÀÇ Ä³¸®¾î ½ºÅ©¸®´× ½ÃÀå(2019-2023³â)
À¯Çüº° ºÎ¹® ºÐ¼®(2019-2023³â)
±â¼úº° ºÎ¹® ºÐ¼®(2019-2023³â)
°Ë»çº° ºÎ¹® ºÐ¼®(2019-2023³â)
Áö¿ªº° ºÎ¹® ºÐ¼®(2019-2023³â)
±¹°¡º° ºÎ¹® ºÐ¼®(2019-2023³â)
Á¦6Àå Á¤¼º ºÐ¼®
AIÀÇ ¿µÇâ : ¼¼°èÀÇ Ä³¸®¾î ½ºÅ©¸®´× ½ÃÀå
Á¦7Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦8Àå ½ÃÀå ¼¼ºÐÈ : À¯Çüº°
½ÃÀå ºÎ¹®
ºñ±³ : À¯Çüº°
È®´ë : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Ç¥Àû Áúȯ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : À¯Çüº°
Á¦9Àå ½ÃÀå ¼¼ºÐÈ : ±â¼úº°
½ÃÀå ºÎ¹®
ºñ±³ : ±â¼úº°
DNA ¹è¿ ºÐ¼® : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR) : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¸¶ÀÌÅ©·Î¾î·¹ÀÌ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : ±â¼úº°
Á¦10Àå ½ÃÀå ¼¼ºÐÈ : °Ë»çº°
½ÃÀå ºÎ¹®
ºñ±³ : °Ë»çº°
ºÐÀÚ ½ºÅ©¸®´× °Ë»ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
»ýÈÇÐ ½ºÅ©¸®´× °Ë»ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : °Ë»çº°
Á¦11Àå °í°´ »óȲ
Á¦12Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
ÀÌÅ»¸®¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ºÆäÀÎ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦13Àå ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ
Á¦14Àå °æÀï ±¸µµ
°³¿ä
°æÀï ±¸µµ
ÆÄ±«Àû Çõ½Å »óȲ
¾÷°è ¸®½ºÅ©
Á¦15Àå °æÀï ºÐ¼®
±â¾÷ °³¿ä
±â¾÷ ¼øÀ§ Áö¼ö
±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
Abbott Laboratories
Agilent Technologies Inc.
Danaher Corp.
DiaSorin SpA
Eurofins Scientific SE
F. Hoffmann La Roche Ltd.
Fulgent Genetics Inc.
Illumina Inc.
Invitae Corp.
Laboratory Corp. of America Holdings
Myriad Genetics Inc.
OPKO Health Inc.
Otogenetics Corporation
Quest Diagnostics Inc.
Thermo Fisher Scientific Inc.
Á¦16Àå ºÎ·Ï
LSH
The carrier screening market is forecasted to grow by USD 3,897.9 mn during 2024-2029, accelerating at a CAGR of 22.5% during the forecast period. The report on the carrier screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of genetic diseases and disorders, increasing prevalence of fetal chromosomal abnormalities, and rising consciousness among masses regarding benefits of early detection and diagnosis of diseases.
Market Scope
Base Year 2025
End Year 2029
Series Year 2025-2029
Growth Momentum Accelerate
YOY 2025 18.1%
CAGR 22.5%
Incremental Value $3,897.9 mn
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's carrier screening market is segmented as below:
By Type
Expanded
Targeted disease
By Technology
DNA sequencing
Polymerase chain reaction (PCR)
Microarrays
Others
By Test
Molecular screening tests
Biochemical screening tests
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the rising trends of next-generation sequencing (NGS) technology in carrier screening as one of the prime reasons driving the carrier screening market growth during the next few years. Also, extensive research and development activities in field of biotechnology and bioinformatics and significant growth in medical infrastructure will lead to sizable demand in the market.
The report on the carrier screening market covers the following areas:
Carrier Screening Market sizing
Carrier Screening Market forecast
Carrier Screening Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading carrier screening market vendors that include Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., DiaSorin SpA, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fulgent Genetics Inc., Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc.. Also, the carrier screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Market Segmentation by Test
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Carrier Screening Market 2019 - 2023
Historic Market Size - Data Table on Global Carrier Screening Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Technology segment analysis 2019 - 2023
Historic Market Size - Technology Segment 2019 - 2023 ($ million)
5.4 Test segment analysis 2019 - 2023
Historic Market Size - Test Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The impact of AI in the global carrier screening market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Expanded - Market size and forecast 2024-2029
Chart on Expanded - Market size and forecast 2024-2029 ($ million)
Data Table on Expanded - Market size and forecast 2024-2029 ($ million)
Chart on Expanded - Year-over-year growth 2024-2029 (%)
Data Table on Expanded - Year-over-year growth 2024-2029 (%)
8.4 Targeted disease - Market size and forecast 2024-2029
Chart on Targeted disease - Market size and forecast 2024-2029 ($ million)
Data Table on Targeted disease - Market size and forecast 2024-2029 ($ million)
Chart on Targeted disease - Year-over-year growth 2024-2029 (%)
Data Table on Targeted disease - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Technology
9.1 Market segments
Chart on Technology - Market share 2024-2029 (%)
Data Table on Technology - Market share 2024-2029 (%)
9.2 Comparison by Technology
Chart on Comparison by Technology
Data Table on Comparison by Technology
9.3 DNA sequencing - Market size and forecast 2024-2029
Chart on DNA sequencing - Market size and forecast 2024-2029 ($ million)
Data Table on DNA sequencing - Market size and forecast 2024-2029 ($ million)
Chart on DNA sequencing - Year-over-year growth 2024-2029 (%)
Data Table on DNA sequencing - Year-over-year growth 2024-2029 (%)
9.4 Polymerase chain reaction (PCR) - Market size and forecast 2024-2029
Chart on Polymerase chain reaction (PCR) - Market size and forecast 2024-2029 ($ million)
Data Table on Polymerase chain reaction (PCR) - Market size and forecast 2024-2029 ($ million)
Chart on Polymerase chain reaction (PCR) - Year-over-year growth 2024-2029 (%)
Data Table on Polymerase chain reaction (PCR) - Year-over-year growth 2024-2029 (%)
9.5 Microarrays - Market size and forecast 2024-2029
Chart on Microarrays - Market size and forecast 2024-2029 ($ million)
Data Table on Microarrays - Market size and forecast 2024-2029 ($ million)
Chart on Microarrays - Year-over-year growth 2024-2029 (%)
Data Table on Microarrays - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Technology
Market opportunity by Technology ($ million)
Data Table on Market opportunity by Technology ($ million)
10 Market Segmentation by Test
10.1 Market segments
Chart on Test - Market share 2024-2029 (%)
Data Table on Test - Market share 2024-2029 (%)
10.2 Comparison by Test
Chart on Comparison by Test
Data Table on Comparison by Test
10.3 Molecular screening tests - Market size and forecast 2024-2029
Chart on Molecular screening tests - Market size and forecast 2024-2029 ($ million)
Data Table on Molecular screening tests - Market size and forecast 2024-2029 ($ million)
Chart on Molecular screening tests - Year-over-year growth 2024-2029 (%)
Data Table on Molecular screening tests - Year-over-year growth 2024-2029 (%)
10.4 Biochemical screening tests - Market size and forecast 2024-2029
Chart on Biochemical screening tests - Market size and forecast 2024-2029 ($ million)
Data Table on Biochemical screening tests - Market size and forecast 2024-2029 ($ million)
Chart on Biochemical screening tests - Year-over-year growth 2024-2029 (%)
Data Table on Biochemical screening tests - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Test
Market opportunity by Test ($ million)
Data Table on Market opportunity by Test ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT
15.5 Agilent Technologies Inc.
Agilent Technologies Inc. - Overview
Agilent Technologies Inc. - Business segments
Agilent Technologies Inc. - Key news
Agilent Technologies Inc. - Key offerings
Agilent Technologies Inc. - Segment focus
SWOT
15.6 Danaher Corp.
Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
SWOT
15.7 DiaSorin SpA
DiaSorin SpA - Overview
DiaSorin SpA - Business segments
DiaSorin SpA - Key news
DiaSorin SpA - Key offerings
DiaSorin SpA - Segment focus
SWOT
15.8 Eurofins Scientific SE
Eurofins Scientific SE - Overview
Eurofins Scientific SE - Business segments
Eurofins Scientific SE - Key offerings
Eurofins Scientific SE - Segment focus
SWOT
15.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.10 Fulgent Genetics Inc.
Fulgent Genetics Inc. - Overview
Fulgent Genetics Inc. - Product / Service
Fulgent Genetics Inc. - Key offerings
SWOT
15.11 Illumina Inc.
Illumina Inc. - Overview
Illumina Inc. - Business segments
Illumina Inc. - Key news
Illumina Inc. - Key offerings
Illumina Inc. - Segment focus
SWOT
15.12 Invitae Corp.
Invitae Corp. - Overview
Invitae Corp. - Product / Service
Invitae Corp. - Key offerings
SWOT
15.13 Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings - Overview
Laboratory Corp. of America Holdings - Business segments
Laboratory Corp. of America Holdings - Key news
Laboratory Corp. of America Holdings - Key offerings
Laboratory Corp. of America Holdings - Segment focus
SWOT
15.14 Myriad Genetics Inc.
Myriad Genetics Inc. - Overview
Myriad Genetics Inc. - Product / Service
Myriad Genetics Inc. - Key news
Myriad Genetics Inc. - Key offerings
SWOT
15.15 OPKO Health Inc.
OPKO Health Inc. - Overview
OPKO Health Inc. - Business segments
OPKO Health Inc. - Key offerings
OPKO Health Inc. - Segment focus
SWOT
15.16 Otogenetics Corporation
Otogenetics Corporation - Overview
Otogenetics Corporation - Product / Service
Otogenetics Corporation - Key offerings
SWOT
15.17 Quest Diagnostics Inc.
Quest Diagnostics Inc. - Overview
Quest Diagnostics Inc. - Business segments
Quest Diagnostics Inc. - Key offerings
Quest Diagnostics Inc. - Segment focus
SWOT
15.18 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
16.6 Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations